About Open Source Pharma Foundation
Open Source Pharma Foundation is a Healthcare company. Development of low-cost medicines through open source principles and global collaborations in healthcare research. Open Source Pharma Foundation offers products and services including Open Source COVID-19 Vaccine and Drug Repurposing. Its focus areas include Biotechnology, Drug Discovery, Open Source Research and Vaccines.
Company details
The Open Source Pharma Foundation is recognized for promoting open source principles to develop affordable medicines, particularly in areas of unmet health needs. Efforts are directed towards collaborative projects like COVID-19 vaccine trials, drug repurposing, and partnerships with global institutions such as WHO and Harvard. Clinical trials for off-patent vaccines and research on innate immunity are undertaken to foster innovation. This approach is supported by events and community building, aiming to create a new paradigm in pharmaceutical development that prioritizes accessibility and shared knowledge, as evidenced by mentions in major publications like The New York Times and Newsweek.
- SectorsHealthcare
- Legal Name Open Source Pharma Foundation
- Date of Incorporation 17 Feb, 2016
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹76,099
FY 2025 · -58% YoY
- Indian entity net loss-₹9.3 Lakh
FY 2025 · -1221% margin
- Indian entity EBITDA-₹9.3 Lakh
FY 2025 · -1221% margin
Associated legal entities of Open Source Pharma Foundation
Open Source Pharma Foundation operates through Open Source Pharma Foundation (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Open Source Pharma Foundation CIN U74900KA2016NPL086274 | Active | 17 Feb 2016 | Bangalore, Karnataka | ₹0.0 Cr | 2 | View details |
Products & Services of Open Source Pharma Foundation
Open Source Pharma Foundation offers a comprehensive portfolio of products and services, including Open Source COVID-19 Vaccine and Drug Repurposing.
Research and clinical trials for vaccines are carried out using open source methodologies to address global health needs
Drug repurposing efforts are focused on exploring existing compounds for new treatments through collaborative platforms
Board of directors of Open Source Pharma Foundation (Open Source Pharma Foundation)
Open Source Pharma Foundation is the primary company behind Open Source Pharma Foundation. The board of Open Source Pharma Foundation currently have 2 directors; the longest-serving is Jaykumar Aravindakshan Menon, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jaykumar Aravindakshan Menon DIN 07229174 | Managing Director | 17 Feb 2016 | 10 yrs 8 mo | Open Source Pharma Foundation |
| Tanjore Balganesh Soundararajan DIN 00648534 | Director | 17 Feb 2016 | 10 yrs 8 mo | Open Source Pharma Foundation |
Financials of Open Source Pharma Foundation
Figures of Open Source Pharma Foundation, the primary company behind Open Source Pharma Foundation, for FY 2025. Revenue was ₹76,099 (-58% year on year). Net loss was -₹9.3 Lakh (-1221% margin). EBITDA was -₹9.3 Lakh (-1221% margin). Revenue has grown at a compounded annual rate of -19% over three years and -67% over five years.
- ₹76,099Revenue · FY 2025 · -58% YoY
- -₹9.3 LakhNet loss · -1221% margin
- -₹9.3 LakhEBITDA · -1221% margin
- -19%Revenue CAGR, 3 years
- -67%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Open Source Pharma Foundation are on its company page.
Detailed financial statements for Open Source Pharma Foundation
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Open Source Pharma Foundation
The primary company behind Open Source Pharma Foundation, Open Source Pharma Foundation, reported revenue of ₹76,099 for FY 2025, down 58% year on year.
The Open Source Pharma Foundation is recognized for promoting open source principles to develop affordable medicines, particularly in areas of unmet health needs. Efforts are directed towards collaborative projects like COVID-19 vaccine trials, drug repurposing, and partnerships with global institutions such as WHO and Harvard. Clinical trials for off-patent vaccines and research on innate immunity are undertaken to foster innovation. This approach is supported by events and community building, aiming to create a new paradigm in pharmaceutical development that prioritizes accessibility and shared knowledge, as evidenced by mentions in major publications like The New York Times and Newsweek.
Open Source Pharma Foundation offers Open Source COVID-19 Vaccine and Drug Repurposing.
Open Source Pharma Foundation operates through Open Source Pharma Foundation.
The legal entities of Open Source Pharma Foundation currently have 2 directors, including Jaykumar Aravindakshan Menon, Tanjore Balganesh Soundararajan.